Skip to content

Survey assessment of the impact of COVID-19 on testing for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region

Take part in a coordinated European assessment of the impact of COVID-19 in testing services for HIV, Hepatitis B, C and Sexually Transmitted Infections.

In order to understand the impact of the COVID-19 pandemic in testing services for HIV, HBV, HCV and STI in the WHO European Region, a consortium of partners including regional European and international organisations representing community, health care and public health institutions have come together to develop a survey to collect information from organisations and services providing testing for one or more of these infections, namely: laboratories, clinicians or clinical services, primary health care units and community organizations.

Results will be used to inform advocacy efforts as well as next steps in the regional response to HIV, viral hepatitis and STI with planned publication(s) for late 2020-2021.

The survey is available in English and Russian, contains 26 questions (depending on type of service) and will take around 20 minutes to complete. It will be open for responses until 1 November 2020.

You can access the survey by clicking here or copy pasting the following link into your browser: https://is.gd/EuroTESTCOVID19impact

You can also find more information on the EuroTEST website by clicking here.

 

Share this page: